Immune System News and Research

RSS

Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

Researchers examined the unique clusters of monocytes and regulatory T cells in the circulating blood from convalescent COVID-19 patients over a prolonged period after recovery, using scRNA sequencing.

31 Mar 2022

Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

Although SARS-CoV-2 has taken the world by storm, it's not the only coronavirus that can infect humans.

30 Mar 2022

Research provides a roadmap for new therapies to treat chorioamnionitis

One of the serious complications that can occur during late pregnancy happens when the amniotic sac (also called the bag of waters) breaks too early, which can allow bacterial infections to cause dangerous tissue inflammation around the placenta.

30 Mar 2022

Soy molasses and kudzu roots may help fight against pediatric tumors

Soy molasses and kudzu roots contain isoflavonoids with high antioxidant and cytotoxic activity, scientists have discovered.

30 Mar 2022

Covid and schizophrenia: Why this deadly mix can deepen knowledge of the brain disease

Most of the time, the voices in Keris Myrick’s head don’t bother her. They stay in the background or say nice things. But sometimes they get loud and mean — like when a deadly pandemic descended on the world.

30 Mar 2022

A bioinformatics approach for detecting SARS-CoV-2 co-infections

Researchers discuss a novel bioinformatics-based method for the detection of SARS-CoV-2 co-infections with the Delta and Omicron variants.

29 Mar 2022

Government provides new guidance for living with COVID

People at risk of serious illness from COVID-19, and eligible for treatments, will continue to get free tests to use if they develop symptoms, along with NHS and adult social care staff and those in other high-risk settings, Health and Social Care Secretary Sajid Javid announced today (Tuesday 29 March).

29 Mar 2022

Study finds less diverse circulating antibodies in aging killifish

As we age, our immune system works less well. We become more susceptible to infections and vaccinations no longer work as effectively.

29 Mar 2022

The different actions of CBD in SARS-CoV-2 infection

An article has described the role of cannabidiol as a potential inhibitor of hyperinflammation in SARS-CoV-2 infection.

29 Mar 2022

One year after severe COVID-19, T cells persist against SARS-CoV-2

In a recently published article in the journal eBioMedicine, scientists have demonstrated that critically ill coronavirus disease 2019 (COVID-19) patients are capable of generating durable memory T cell response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than one year after hospital discharge.

28 Mar 2022

Tumor cells camouflage as platelets to go undetected in the bloodstream, finds study

The Liquid Biopsy and Cancer Interception research group—part of the Biohealth Research Institute in Granada (ibs.GRANADA), in which researchers from the University of Granada (UGR) participate—has discovered that tumor cells pass themselves off as platelets to go undetected in the bloodstream.

28 Mar 2022

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of aggressive bladder tumor growth, according to a proof-of-concept study led by Cedars-Sinai Cancer investigators.

28 Mar 2022

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

Researchers study the impact of pasteurization on specific Ig concentration against SARS-CoV-2 in milk from mRNA vaccinated lactating women.

27 Mar 2022

CDK6: a potential drug target for severe COVID-19

Researchers identify a methodology and workflow to repurpose drugs against the cyclin-dependent kinase 6 target gene of SARS-CoV-2.

27 Mar 2022

New trial examines the effectiveness of a two-pronged immunotherapy for glioblastomas

A new clinical trial at the University of Cincinnati is studying the effectiveness of a new two-pronged immunotherapy treatment procedure to treat the most aggressive and deadly type of brain tumors, called glioblastomas. Originating from healthy brain cells, glioblastomas can form in any area of the brain.

25 Mar 2022

Immune System News and Research

Study determines the molecular signatures of monocytes and regulatory T cells in the circulating blood of COVID-19 patients

Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

Research provides a roadmap for new therapies to treat chorioamnionitis

Soy molasses and kudzu roots may help fight against pediatric tumors

Covid and schizophrenia: Why this deadly mix can deepen knowledge of the brain disease

A bioinformatics approach for detecting SARS-CoV-2 co-infections

Government provides new guidance for living with COVID

Study finds less diverse circulating antibodies in aging killifish

The different actions of CBD in SARS-CoV-2 infection

One year after severe COVID-19, T cells persist against SARS-CoV-2

Tumor cells camouflage as platelets to go undetected in the bloodstream, finds study

Novel drug combination can boost chemoimmunotherapy response in bladder cancer patients

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

CDK6: a potential drug target for severe COVID-19

New trial examines the effectiveness of a two-pronged immunotherapy for glioblastomas

Researchers show how an important inhibitor binds to the A2A receptor

New model reveals how antibodies navigate pathogen surfaces like a child at play

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

INRS professor developing a glycoconjugate vaccine for melioidosis

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

Immunology eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News